PGC-1α Promotes NSCLC Progression via FOXM1 Interaction and MUC1 Upregulation
Cancer Biotherapy and Radiopharmaceuticals · 2025
DOI: 10.1089/cbr.2025.0072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2025. Verfasst von Tianyi Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Forkhead Box Protein M1, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha. Die Arbeit nennt 49 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dalian Medical University, Dalian, China.
- Department of Thoracic Surgery, Lung Cancer Diagnosis and Treatment Center of Dalian, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
- Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
ORCID-Profile: Chundong Gu
Zitieren
APA
Zhang, T., Li, Z., Wang, S., Zhao, S., Gao, C., Qi, Y., & Gu, C. (2025). PGC-1α Promotes NSCLC Progression via FOXM1 Interaction and MUC1 Upregulation. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.2025.0072
Vancouver
Zhang T, Li Z, Wang S, Zhao S, Gao C, Qi Y, et al. PGC-1α Promotes NSCLC Progression via FOXM1 Interaction and MUC1 Upregulation. Cancer Biotherapy and Radiopharmaceuticals. 2025. doi:10.1089/cbr.2025.0072
BibTeX
@article{Zhang2025,
author = {Zhang, Tianyi and Li, Zhuoshi and Wang, Shiqing and Zhao, Shilei and Gao, Chao and Qi, Yangfan and Gu, Chundong},
title = {PGC-1α Promotes NSCLC Progression via FOXM1 Interaction and MUC1 Upregulation},
journal = {Cancer Biotherapy and Radiopharmaceuticals},
year = {2025},
doi = {10.1089/cbr.2025.0072}
}
EUVIMED